¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"secondary disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • chronic granulomatous disease
    ¸¸¼ºÀ°¾ÆÁ¾º´
  • chronic obstructive pulmonary disease
    ¸¸¼ºÆó¼âÆóÁúȯ
  • deficiency disease
    °áÇ̺´
  • degenerative disease
    ÅðÇິ, º¯¼ºº´
  • degenerative joint disease
    ÅðÇà°üÀýº´
  • demyelinating disease
    ¸»ÀÌÁýÅ»¶ôº´, Å»¼öÃʺ´
  • dense deposit disease
    °í¹ÐµµÄ§Âøº´
  • depression spectrum disease
    ¿ì¿ï½ºÆåÆ®·³º´
  • de Quervain¡¯s disease
    µåÄù¸£¹ðº´
  • diarrheal disease
    ¼³»çº´
  • diffuse Lewy body disease
    ±¤¹üÀ§·¹ºñ¼Òüº´
  • digestive tract disease
    ¼ÒÈ­°üº´
  • disease
    º´, Áúº´, Áúȯ
  • disease control
    Áúº´°ü¸®
  • disease entity
    Áúº´´ÜÀ§, Áúº´¸í
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • digestive tract disease
    ¼ÒÈ­°üº´
  • disease detection
    Áúº´¹ß°ß
  • disease entity
    Áúº´´ÜÀ§, Áúº´¸í
  • disease potential
    Áúº´ÀáÀç·Â
  • disease registry
    Áúº´µî·Ïü°è
  • disease susceptibility
    Áúº´°¨¼ö¼º
  • disease taxonomy
    Áúº´ºÐ·ùÇÐ
  • disease vector
    Áúº´¸Å°³Ã¼
  • disease free survival
    ¹«º´»ýÁ¸
  • disease frequency survey
    Áúº´ºóµµÁ¶»ç
  • disease odds ratio
    Áúº´±³Â÷ºñ
  • dust disease
    ¸ÕÁöº´
  • endemic disease
    dzÅ亴
  • enzootic disease
    µ¿¹°ÅäÂøº´
  • epidemic disease
    À¯Çິ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • Herlitz disease => generalized junctinal epidermolysis bullosa
    Àü½Å¼º °æ°è¼º ¼öÆ÷¼º Ç¥Çǹڸ®Áõ
  • Hers disease
    Ç㽺º´
  • Hirschsprung s disease
    Ç츣½¬½ºÇÁ·îº´.
  • Hirschsprungs disease
    È÷¸£½¬½ºÇÁ·îº´
  • Hodgkin s disease =malignant lymphoma
    È£ÁîŲº´.
  • Hodgkin s disease =malignant lymphoma
    È£ÁîŲº´.
  • Huntingtons disease
    ÇãÆÃÅæ¹«µµº´
  • Huntingtons disease
    ÇåÆÃÅæ º´
  • Hyaline membrane disease
    À¯¸®Áú¸·º´(ë¤×ãòõدܻ)
  • Internation Classification of Disease(ICD)
    ±¹Á¦Áúº´ºÐ·ù.
  • Jacob-Creutzfeldt disease
    ¾ßÄß-Å©·çÃ÷ÆçÆ®º´
  • Johnes disease
    ÁÔÁúȯ
  • Kahler s disease
    Ä®·¯º´.
  • Kawasaki disease
    °¡¿Í»ç³¢º´, Á¡¸·ÇǺθ²ÇÁÀý ÁõÈıº (±Þ¼º¿­¼º)
  • Kawasaki disease => mucocutaneous lymph node syndrome
    °¡¿Í»çŰ º´
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • secondary hyperparathyroidism
    ¼Ó¹ß¼º ºÎ°©»ó¼± ±â´ÉÇ×Áø(Áõ)(¼Ó¹ß¼ººÎ°©»ó ¼±±â´ÉÇ×ÁøÁõ).
  • secondary hyperparathyroidism
    ¼Ó¹ß¼º ºÎ°©»ó¼± ±â´ÉÇ×Áø(Áõ)(áÙÛ¡àõÜùË£ßÒ àÍѦÒöùñòäñø).
  • secondary hyperparathyroidism
    ¼Ó¹ß¼º ºÎ°©»ó¼± ±â´ÉÇ×Áø(Áõ)(áÙÛ¡àõÜùË£ßÒàÍѦÒöùñòäñø)
  • secondary hyperplastic osteitis
    ÀÌÂ÷¼º Áõ½Ä¼º °ñ¿°(ì£ó­àõñòãÖàõÍéæú).
  • secondary hyperplastic osteitis
    ÀÌÂ÷¼º Áõ½Ä¼º °ñ¿°(ì£ó­àõñòãÖàõÍéæú)
  • secondary hypertension
    ÀÌÂ÷¼º °íÇ÷¾Ð (¡­ÍÔúìäâ).
  • secondary hypertension
    ÀÌÂ÷¼º °íÇ÷¾Ð (¡­ÍÔúìäâ)
  • secondary hypertrophic osteoarthropathy
    ¼Ó¹ß¼º ºñ´ë¼º °ñ°üÀýº´Áõ(¡­ÝþÓÞàõ Íéμï½Ü»ñø).
  • secondary hypertrophic osteoarthropathy
    ¼Ó¹ß¼º ºñ´ë¼º °ñ°üÀýº´Áõ(¡­ÝþÓÞàõ Íéμï½Ü»ñø)
  • secondary hypogonadism
    ¼Ó¹ß¼º ¼º¼±±â´ÉÀúÇÏ(¡­àõàÍѦÒöî¸ù»).
  • secondary hypogonadism
    ¼Ó¹ß¼º ¼º¼±±â´ÉÀúÇÏ(¡­àõàÍѦÒöî¸ù»)
  • secondary immune response
    ÀÌÂ÷Àû ¸é¿ª¹ÝÀÀ(ì£ó­îÜØóæ¹Úãëë).
  • secondary immune response
    ÀÌÂ÷Àû ¸é¿ª¹ÝÀÀ(ì£ó­îÜØóæ¹Úãëë).
  • secondary inclusion
    ÀÌÂ÷ºÀÀÔü(¡­Üæìýô÷).
  • secondary inclusion
    ÀÌÂ÷ºÀÀÔü(¡­Üæìýô÷)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
AR   1) Aortic Regurgitation
    = AI
  Echo¼Ò°ß
 &...
CEA Carcino-Embryonic Antigen [HP 1825-6]
  ; Oncofetal Antigens
  ; Glycopro...
IHD Ischemic Heart Disease
  = Coronary Heart(Artery) Disease
  = Atheroscler...
LCP Disease Legg-Calve-Perthes Disease
  ? Stages of LCP Disease(= Juvenile Idiopathic AVN)
&nb...
AID acquired immunodeficiency disease; acute infectious disease; acute ionization detector; Agency for I...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
ASCVD Atherosclerotic cardiovascular disease
AD Aujeszky disease
ADV Aujeszky Disease Virus
AITD Autoimmune Thyroid Disease
ATD Autoimmune thyroid disease
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • collagen-vascular disease
    ±³¿øÁú-Ç÷°ü¼º Áúȯ
  • combined immunodeficiency disease
    º¹ÇÕÇü ¸é¿ª °áÇÌ Áúȯ
  • combined system disease
    º¹ÇÕ °èÅë Áúȯ
  • combined valvular disease
    º¹ÇÕ ÆÇ¸· Áúȯ
  • connective tissue disease
    °áÇÕÁ¶Á÷ º´, °áÇÕÁ¶Á÷ Áúȯ
  • consumption disease
    ¼Ò¸ð¼º Áúȯ
    ü·ÂÀÇ ¼Ò¸ð. Àü¿¡´Â Æó °áÇÙ¿¡ ´ëÇÏ¿© »ç¿ëµÇ¾ú´Ù.
  • Creutzfeldt-Jakob disease
    ¾ß°ö º´
    ÁßÃ߽Űæ°è¸¦ ħ¹üÇÏ´Â ¹ÙÀÌ·¯½º¼º °¨¿° Áúȯ. Ä¡¸Å°¡ ¿À°Ô µÇ°í °£´ë¼º °æ·ÃÀ» º¸ÀÌ´Ù°¡ »ç¸ÁÇÏ°Ô µÇ´Â °£¿°¼º ÁúȯÀÌ´Ù. Àü¼¼°èÀûÀ¸·Î ºÐÆ÷µÇ¾î ÀÖÀ¸¸ç, Å©·ÎÀÌÃ÷ÆçÆ®-¾ß°ö º´À̶ó°íµµ ÇÑ´Ù. Àü¿° °æ·Î´Â È®½ÇÇÏ°Ô ¾Ë·ÁÁ® ÀÖÁö ¾ÊÀ¸³ª, 1996³â ¿µ±¹¿¡¼­ ¹ßº´ÇÑ ±¤¿ìº´
  • Crohn's disease
    Crohn Áúȯ, Å©·Ð¾¾ º´, Å©·Ð º´
    Å©·ÐÀÌ 1932³â óÀ½À¸·Î ȸÀå ¸»´ÜÀÇ Àå¿°À» ±¹ÇÑÀû ȸÀå¿°À¸·Î ±âÀçÇÑ °Í. ȸÀå ¸»´Ü¿°. ¼ÒÀå, ´ëÀå¿¡¼­µµ º¼ ¼ö ÀÖÀ¸¸ç ȸÀå ¸»´ÜºÎÀÇ °ÅÀÇ 30cm¿¡ ÀÚÁÖ ¹ß»ýÇϰí Á¡¸·¿¡¼­ Á¡¸· ÇÏÃþ¿¡ ¹ÌÄ¡´Â ¿°Áõ¼º º¯È­·Î À°¾Æ °Å´ë¼¼Æ÷¸¦ º¼ ¼ö ÀÖ´Ù. ¿øÀÎÀº Àå³» ¼¼±Õ, ¾Ë·¯Áö µîÀÇ ¿¬°üµÈ °ÍÀ¸·Î º¸ÀδÙ.
  • cyanotic heart disease
    û»ö¼º ½ÉÀå Áúȯ
  • cytomegalic inclusion disease
    ¼¼Æ÷ °Å´ë¼º ºÀÀÔü º´, °Å´ë ¼¼Æ÷ ºÀÀÔü Áúȯ
  • cytomegaloviral disease
    °Å´ë ¼¼Æ÷ ¹ÙÀÌ·¯½º Áúȯ
  • Darier's disease
    ´ë¸®¾î º´
    µ¿ÀǾî=
  • degenerative brain disease
    ÅðÇ༺ ³ú Áúȯ
  • degenerative disease
    ÅðÇ༺ Áúȯ
  • degenerative joint disease
    ÅðÇ༺ °üÀý Áúȯ
    °üÀý ±¸Á¶¹°¿¡ ÀûÀÀ ÇѰ踦 ³Ñ¾î¼­´Â ÈûÀÌ °è¼Ó °¡ÇØÁö¸é °üÀý¸é, Ȱ¸·, °üÀý³¶¿¡ ¿°Áõ¼º º´º¯ÀÌ »ý±â´Â °æ¿ì.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
secondary suture Delayed closure of a wound.
(05 Mar 2000)
secondary syphilid A syphilitic skin lesion characteristic of the second stage of the disease.
(05 Mar 2000)
secondary syphilis The second stage of syphilis
See: syphilis.
Synonym: mesosyphilis.
(05 Mar 2000)
secondary teeth <dentistry> The permanent teeth, i.e. The second group of teeth to come in.
(08 Jan 1998)
secondary telangiectasia Telangiectasia related to a known cause of prolonged dermal vascular dilatation such as sunlight, varicose veins, and connective tissue diseases; often associated with atrophy of the skin.
(05 Mar 2000)
secondary thrombus A thrombus formed about an embolus as a nucleus.
(05 Mar 2000)
secondary tuberculosis Tuberculosis found in adults and characterised by lesions near the apex of an upper lobe, which may cavitate or heal with scarring without spreading to lymph nodes; theoretically, secondary tuberculosis may be due to exogenous reinfection or to reactivation of a dormant endogenous infection.
Synonym: adult tuberculosis, postprimary tuberculosis, reinfection tuberculosis.
(05 Mar 2000)
secondary tumour <oncology> A tumour that develops as a result of metastasis or spreads beyond the original cancer.
(09 Oct 1997)
secondary tympanic membrane The membrane closing the fenestra cochleae or rotunda.
Synonym: membrana tympani secundaria, Scarpa's membrane.
(05 Mar 2000)
secondary union Delayed closure of two granulating surfaces.
Synonym: secondary adhesion, secondary union.
(05 Mar 2000)
secondary villus An intermediate stage of chorionic villus development following invasion by a connective tissue core.
(05 Mar 2000)
secondary visual area Area of the occipital lobe concerned with vision.
(12 Dec 1998)
secondary visual cortex See: visual cortex.
(05 Mar 2000)
secondary vitreous Avascular vitreous formed around the primary vitreous.
(05 Mar 2000)
secondary wall <plant biology> The part of the plant cell wall which is laid down on top of the primary wall after the wall has ceased to increase in surface area. Only occurs in certain cell types, for example tracheids, vessel elements and sclerenchyma. Differs from the primary wall both in composition and structure and is often diagnostic for a particular cell type.
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
ÅëÇÕ°Ë»ö ¿Ï·á